A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumours
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (11), 1589-1592
- https://doi.org/10.1016/0959-8049(93)90300-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tissue-specific distribution of cross-linked somatostatin receptor proteins in the ratBiochemical Journal, 1992
- The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of TumorsEndocrine Reviews, 1991
- Growth of Human Breast Cancer Cell Lines Is Inhibited by the Somatostatin Analog BIM23014*Endocrinology, 1991
- Comparison of Somatuline (BIM‐23014) and somatostatin on endocrine and exocrine activities in the ratDrug Development Research, 1991
- Evidence for Multiple Protein Constituents of the Somatostatin Receptor in Pituitary Tumor Cells: Affinity Cross-Linking and Molecular Characterization*Endocrinology, 1989
- Characterization of 17-β-Estradiol-dependent and -independent Somatostatin Receptor Subtypes in Rat Anterior PituitaryPublished by Elsevier ,1989
- Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancerJournal of Clinical Laboratory Analysis, 1989
- In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogueBiochemical and Biophysical Research Communications, 1988
- Differential Binding of Somatostatin Agonists to Somatostatin Receptors in Brain and AdenohypophysisNeuroendocrinology, 1987
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973